The ZCCHC12 gene is associated with non-syndromic mental retardation, a condition characterized by intellectual disabilities that do not coincide with other physical or neurological symptoms. Genetic testing for mutations in the ZCCHC12 gene can help in diagnosing this specific form of mental retardation, allowing for better-informed decisions regarding management and care. DNA Labs UAE offers a specialized genetic test to identify mutations in the ZCCHC12 gene. The cost of this test is 4400 AED. By undergoing this test, individuals can gain valuable insights into their genetic makeup, potentially leading to early intervention and support strategies that can improve quality of life.
The ATRX Gene Mental Retardation with Hypotonic Facies Syndrome X-Linked Genetic Test is a specialized diagnostic procedure designed to identify mutations in the ATRX gene, which are associated with a rare genetic condition. This condition, often referred to as ATR-X syndrome, is characterized by intellectual disability, facial dysmorphism, and other physical abnormalities. The test plays a crucial role in the early diagnosis and management of the syndrome, enabling healthcare professionals to provide targeted interventions and support for affected individuals.
Conducted at DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities, the test involves collecting a DNA sample from the patient, usually through a blood draw or cheek swab. The sample is then analyzed for specific mutations in the ATRX gene that are known to cause the syndrome.
The cost of the ATRX Gene Mental Retardation with Hypotonic Facies Syndrome X-Linked Genetic Test is set at 4400 AED. This price reflects the comprehensive nature of the test, including the sophisticated technology and expertise required to accurately identify the genetic mutations associated with the condition. Patients considering this test are advised to consult with their healthcare provider to understand its benefits and implications fully.
The SMARCA1 gene plays a crucial role in regulating gene expression and is involved in chromatin remodeling. Mutations in the SMARCA1 gene have been associated with X-linked mental retardation and other developmental disorders. The genetic test for SMARCA1-related conditions is designed to identify mutations in the SMARCA1 gene that may lead to intellectual disabilities and other symptoms associated with the disorder.
At DNA Labs UAE, a specialized genetic test is offered to diagnose conditions related to mutations in the SMARCA1 gene. This test is particularly important for families with a history of X-linked mental retardation or for individuals showing symptoms related to SMARCA1 mutations. Early diagnosis through genetic testing can aid in understanding the condition better, allowing for appropriate management and support.
The cost of the SMARCA1 Gene Mental Retardation X-linked SMARCA1 Related Genetic Test at DNA Labs UAE is 4400 AED. This comprehensive test is conducted by experienced professionals using advanced genetic testing technologies to ensure accuracy and reliability of the results. By opting for this test, individuals can gain valuable insights into their genetic makeup, paving the way for personalized medical care and interventions tailored to their specific needs.
The KDM5C Gene Mental Retardation X-linked Syndromic Claes-Jensen Type Genetic Test is a specialized diagnostic procedure designed to identify mutations in the KDM5C gene, which are linked to Claes-Jensen type mental retardation. This condition is an X-linked syndrome, meaning it primarily affects males and is passed down through the maternal line. Symptoms can include intellectual disability, developmental delays, and sometimes physical abnormalities.
This genetic test involves analyzing the patient's DNA, extracted from a blood sample, to look for specific mutations in the KDM5C gene that are known to cause the syndrome. The process is highly accurate and can provide crucial information for families regarding prognosis, management, and genetic counseling.
Conducted at DNA Labs UAE, a leading facility in genetic diagnostics, the test ensures confidentiality, precision, and reliability. The cost of the test is set at 4400 AED, reflecting the sophisticated technology and expertise required to perform this intricate analysis. For families facing the challenges of X-linked mental retardation syndromes, this test represents a vital step towards understanding and managing the condition.
The MECP2 Gene Mental Retardation X-linked Syndromic Lubs Type Genetic Test is a specialized diagnostic tool designed to detect mutations in the MECP2 gene, which are associated with Lubs type X-linked mental retardation. This condition, part of a spectrum of MECP2-related disorders, is characterized by intellectual disability, developmental delays, and sometimes physical abnormalities. The test is crucial for early diagnosis and intervention, providing valuable information for managing the condition and counseling affected families.
Performed at DNA Labs UAE, a leading facility in genetic testing, this test employs advanced genetic sequencing techniques to analyze the MECP2 gene for any abnormalities that may indicate the presence of the disorder. The cost of the test is 4400 AED, reflecting the sophisticated technology and expertise required to accurately identify mutations in the MECP2 gene. By opting for this test, individuals and families gain access to crucial genetic information that can guide clinical management and therapeutic strategies, ultimately enhancing the quality of life for those affected by Lubs type X-linked mental retardation.
The POMK gene limb-girdle muscular dystrophy autosomal recessive type 12C genetic test is a specialized diagnostic procedure aimed at identifying mutations in the POMK gene, which are responsible for causing limb-girdle muscular dystrophy type 12C (LGMDR12). This form of muscular dystrophy is characterized by progressive weakness and wasting of the limb-girdle muscles, which are the muscles around the shoulders and hips. Early symptoms often include difficulty walking or climbing stairs, and the condition can progressively lead to more severe mobility issues.
The test is conducted by DNA Labs UAE, a reputable facility known for its advanced genetic testing capabilities. The procedure involves collecting a DNA sample, typically through a blood draw or cheek swab, which is then analyzed in the laboratory to detect any genetic mutations in the POMK gene. Identifying these mutations can confirm a diagnosis of LGMDR12, which is crucial for the management and treatment of the condition.
The cost of the test is set at 4400 AED, reflecting the specialized nature of the analysis and the expertise required to accurately interpret the results. For individuals showing symptoms of limb-girdle muscular dystrophy or those with a family history of the condition, this test provides a valuable diagnostic tool. It not only aids in confirming the specific type of muscular dystrophy but also helps in guiding treatment decisions and genetic counseling for affected families.
The CAPN3 gene is associated with a condition known as Limb-girdle muscular dystrophy type 2A (LGMD2A), which is an autosomal recessive disorder. This condition primarily affects the muscles around the hips and shoulders (the limb-girdle area), leading to progressive weakness and wasting. The CAPN3 gene encodes for a protein called calpain 3, which plays a crucial role in muscle function and repair. Mutations in the CAPN3 gene disrupt the normal functioning of calpain 3, leading to the symptoms observed in LGMD2A.
To diagnose this condition, genetic testing of the CAPN3 gene can be performed. This test looks for mutations in the CAPN3 gene that are known to cause Limb-girdle muscular dystrophy type 2A. It is a vital tool for confirming the diagnosis, understanding the disease's progression, and making informed decisions about management and treatment.
In the United Arab Emirates, DNA Labs UAE offers this genetic test for individuals suspected of having LGMD2A or for those who may be carriers of the condition. The test cost is 4400 AED. Conducting this test at DNA Labs UAE provides a reliable diagnosis, aiding in the proper management of the condition and potentially guiding family planning decisions for affected individuals or families.
The DYSF Gene Limb-Girdle Muscular Dystrophy Autosomal Recessive Type 2B Genetic Test is a specialized diagnostic procedure offered by DNA Labs UAE, designed to identify mutations in the DYSF gene. This gene is crucial for the proper functioning of muscles, and mutations can lead to Limb-Girdle Muscular Dystrophy Type 2B (LGMD2B), a condition characterized by progressive weakness and wasting of the limb-girdle muscles, which are those around the hips and shoulders. LGMD2B is an autosomal recessive disorder, meaning that an individual must inherit two copies of the mutated gene, one from each parent, to be affected.
The test involves analyzing the patient's DNA, usually extracted from a blood sample, to detect any abnormalities in the DYSF gene. This genetic testing is essential for confirming the diagnosis of LGMD2B, understanding the risk of passing the disorder to future generations, and making informed decisions about management and treatment options.
The cost of the DYSF Gene Limb-Girdle Muscular Dystrophy Autosomal Recessive Type 2B Genetic Test at DNA Labs UAE is 4400 AED. This investment covers the comprehensive analysis required to identify the specific mutations in the DYSF gene that are responsible for the condition. Early diagnosis through this test can be crucial for the timely initiation of supportive therapies and interventions to manage symptoms and improve the quality of life for affected individuals.
The SGCG gene plays a crucial role in the development and function of muscles in the body. Mutations in this gene can lead to a condition known as limb-girdle muscular dystrophy type 2C (LGMD2C), which is an autosomal recessive disorder. This means that an individual must inherit two copies of the mutated gene, one from each parent, to be affected by the condition. LGMD2C primarily affects the voluntary muscles around the hips and shoulders (the limb-girdle muscles), leading to progressive weakness and wasting of these muscle groups.
Genetic testing for mutations in the SGCG gene is a critical step in diagnosing LGMD2C. This test can confirm the presence of mutations in the gene, helping in the diagnosis and management of the condition. At DNA Labs UAE, individuals can undergo the SGCG gene test, which is a sophisticated genetic analysis aimed at identifying mutations associated with limb-girdle muscular dystrophy type 2C.
The cost of the SGCG gene test at DNA Labs UAE is 4400 AED. This test is conducted with high precision and accuracy, utilizing advanced genetic sequencing technologies to detect mutations in the SGCG gene. By opting for this test, patients and their families can gain valuable insights into the genetic basis of their condition, enabling them to make informed decisions about treatment and management options.
The SGCA gene plays a crucial role in the development and function of muscles in the human body. Mutations in the SGCA gene can lead to Limb-girdle muscular dystrophy type 2D (LGMD2D), which is an autosomal recessive disorder. This condition is characterized by progressive weakness and wasting of the limb-girdle muscles, which are the muscles around the shoulders and hips. Early symptoms often include difficulty running or climbing stairs, and the condition can progressively lead to more severe muscle weakness.
To diagnose this specific type of muscular dystrophy, genetic testing is utilized to identify mutations in the SGCA gene. At DNA Labs UAE, a specialized test for the SGCA gene Limb-girdle muscular dystrophy autosomal recessive type 2D is available. This test is crucial for confirming the diagnosis, understanding the progression of the disease, and making informed decisions about management and treatment options.
The cost of the SGCA gene Limb-girdle muscular dystrophy autosomal recessive type 2D genetic test at DNA Labs UAE is 4400 AED. This test is a vital resource for individuals experiencing symptoms of limb-girdle muscular dystrophy, as well as for families with a history of the condition, as it provides essential genetic information that can aid in diagnosis and future planning.
